Home > Products > CD16 & EGFR
> Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (scFv-IgG)
Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (scFv-IgG) (CAT#: BSSG-036)
Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (scFv-IgG) is formed by an IgG and two scFv fragments. The scFvs from an anti-CD16 antibody variable domain are respectively connected to the N terminus of the anti-EGFR IgG heavy chains or light chains to form scFv-(H)IgG or scFv-(L)IgG. It is a type of appended IgGs and has 2+2 antigen-binding valency. This BsAb can retarget NK cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.
Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors
There are currently no customer reviews or questions for Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (scFv-IgG) (BSSG-036). Click the button below to contact us or submit your feedback about this product.